panel: myth vs reality - implementing payment arrangements for cell and gene therapies
Published 4 years ago • 734 plays • Length 55:09Download video MP4
Download video MP3
Similar videos
-
58:25
panel: current realities of make vs. buy for cell & gene therapy manufacturing
-
1:02:29
panel: safety and efficacy considerations for cell and gene therapies
-
41:38
panel: durable gmp compliance for cell and gene therapies
-
23:40
expediting the development of cell and gene therapy
-
46:39
what’s next for cell and gene therapies in 2023 and beyond
-
59:51
panel: what cell & gene therapy investors are looking for now
-
1:00:31
cell and gene therapies manufacturing: exploring next-generation platform technologies
-
49:16
panel: the state of investment in cell and gene therapy
-
52:32
panel: when does investing in cell and gene therapy make business sense?
-
47:01
panel: optimization of gene therapies: consideration of platform technologies
-
1:11:29
panel: acceptance and uptake of cell and gene therapies: lessons learned and future focus
-
1:09:06
the future of cdmo networks in cell and gene therapy
-
53:56
panel: cell and gene therapies for ophthalmologic diseases
-
16:25
fda’s efforts to advance the development and approval of cellular and gene therapies
-
58:39
panel: navigating regenerative medicine technology assessment and reimbursement
-
2:05
the challenges of cmc in cell and gene therapies
-
3:08
a new model for cell and gene therapies
-
59:51
panel: next generation cell and gene therapy in oncology